Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 223

Similar articles for PubMed (Select 20348879)

1.

Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin.

Rosenwald S, Gilad S, Benjamin S, Lebanony D, Dromi N, Faerman A, Benjamin H, Tamir R, Ezagouri M, Goren E, Barshack I, Nass D, Tobar A, Feinmesser M, Rosenfeld N, Leizerman I, Ashkenazi K, Spector Y, Chajut A, Aharonov R.

Mod Pathol. 2010 Jun;23(6):814-23. doi: 10.1038/modpathol.2010.57. Epub 2010 Mar 26.

2.

Accurate classification of metastatic brain tumors using a novel microRNA-based test.

Mueller WC, Spector Y, Edmonston TB, St Cyr B, Jaeger D, Lass U, Aharonov R, Rosenwald S, Chajut A.

Oncologist. 2011;16(2):165-74. doi: 10.1634/theoncologist.2010-0305. Epub 2011 Jan 27.

3.

Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M.

J Clin Oncol. 2009 Apr 20;27(12):2030-7. doi: 10.1200/JCO.2008.19.4134. Epub 2009 Mar 9.

4.

A second-generation microRNA-based assay for diagnosing tumor tissue origin.

Meiri E, Mueller WC, Rosenwald S, Zepeniuk M, Klinke E, Edmonston TB, Werner M, Lass U, Barshack I, Feinmesser M, Huszar M, Fogt F, Ashkenazi K, Sanden M, Goren E, Dromi N, Zion O, Burnstein I, Chajut A, Spector Y, Aharonov R.

Oncologist. 2012;17(6):801-12. doi: 10.1634/theoncologist.2011-0466. Epub 2012 May 22.

5.

Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.

Varadhachary GR, Spector Y, Abbruzzese JL, Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S, Macinskas J, Lenzi R, Chajut A, Edmonston TB, Raber MN.

Clin Cancer Res. 2011 Jun 15;17(12):4063-70. doi: 10.1158/1078-0432.CCR-10-2599. Epub 2011 Apr 29.

6.

MicroRNAs accurately identify cancer tissue origin.

Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M, Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, Bentwich Z, Cohen D, Chajut A, Barshack I.

Nat Biotechnol. 2008 Apr;26(4):462-9. doi: 10.1038/nbt1392. Epub 2008 Mar 23.

PMID:
18362881
7.

MicroRNA expression differentiates between primary lung tumors and metastases to the lung.

Barshack I, Lithwick-Yanai G, Afek A, Rosenblatt K, Tabibian-Keissar H, Zepeniuk M, Cohen L, Dan H, Zion O, Strenov Y, Polak-Charcon S, Perelman M.

Pathol Res Pract. 2010 Aug 15;206(8):578-84. doi: 10.1016/j.prp.2010.03.005. Epub 2010 Apr 24.

PMID:
20418022
8.

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.

Tothill RW, Kowalczyk A, Rischin D, Bousioutas A, Haviv I, van Laar RK, Waring PM, Zalcberg J, Ward R, Biankin AV, Sutherland RL, Henshall SM, Fong K, Pollack JR, Bowtell DD, Holloway AJ.

Cancer Res. 2005 May 15;65(10):4031-40. Erratum in: Cancer Res. 2005 Sep 1;65(17):8057.

9.

Accurate molecular classification of kidney cancer subtypes using microRNA signature.

Youssef YM, White NM, Grigull J, Krizova A, Samy C, Mejia-Guerrero S, Evans A, Yousef GM.

Eur Urol. 2011 May;59(5):721-30. doi: 10.1016/j.eururo.2011.01.004. Epub 2011 Jan 13.

PMID:
21272993
10.

Molecular profiling of renal cancer: the journey to clinical application.

Ribal MJ.

Eur Urol. 2011 May;59(5):731-3. doi: 10.1016/j.eururo.2011.01.039. Epub 2011 Feb 1. No abstract available.

PMID:
21296486
11.

Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues.

Mullins M, Perreard L, Quackenbush JF, Gauthier N, Bayer S, Ellis M, Parker J, Perou CM, Szabo A, Bernard PS.

Clin Chem. 2007 Jul;53(7):1273-9. Epub 2007 May 24.

12.

Implementation of a novel microarray-based diagnostic test for cancer of unknown primary.

van Laar RK, Ma XJ, de Jong D, Wehkamp D, Floore AN, Warmoes MO, Simon I, Wang W, Erlander M, van't Veer LJ, Glas AM.

Int J Cancer. 2009 Sep 15;125(6):1390-7. doi: 10.1002/ijc.24504.

PMID:
19536816
13.

Efficient identification of miRNAs for classification of tumor origin.

Søkilde R, Vincent M, Møller AK, Hansen A, Høiby PE, Blondal T, Nielsen BS, Daugaard G, Møller S, Litman T.

J Mol Diagn. 2014 Jan;16(1):106-15. doi: 10.1016/j.jmoldx.2013.10.001. Epub 2013 Nov 5.

PMID:
24211363
14.

Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.

Monzon FA, Medeiros F, Lyons-Weiler M, Henner WD.

Diagn Pathol. 2010 Jan 13;5:3. doi: 10.1186/1746-1596-5-3.

15.

MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas.

Tömböl Z, Eder K, Kovács A, Szabó PM, Kulka J, Likó I, Zalatnai A, Rácz G, Tóth M, Patócs A, Falus A, Rácz K, Igaz P.

Mod Pathol. 2010 Dec;23(12):1583-95. doi: 10.1038/modpathol.2010.164. Epub 2010 Sep 3.

16.

High-throughput miRNA profiling of human melanoma blood samples.

Leidinger P, Keller A, Borries A, Reichrath J, Rass K, Jager SU, Lenhof HP, Meese E.

BMC Cancer. 2010 Jun 7;10:262. doi: 10.1186/1471-2407-10-262.

17.

Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.

Staub E, Buhr HJ, Gröne J.

Oncogene. 2010 Aug 5;29(31):4485-92. doi: 10.1038/onc.2010.196. Epub 2010 May 31.

PMID:
20514016
18.

RT-PCR-based gene expression profiling for cancer biomarker discovery from fixed, paraffin-embedded tissues.

Scott A, Ambannavar R, Jeong J, Liu ML, Cronin MT.

Methods Mol Biol. 2011;724:239-57. doi: 10.1007/978-1-61779-055-3_15.

PMID:
21370017
19.

MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling.

Glud M, Klausen M, Gniadecki R, Rossing M, Hastrup N, Nielsen FC, Drzewiecki KT.

J Invest Dermatol. 2009 May;129(5):1219-24. doi: 10.1038/jid.2008.347. Epub 2008 Nov 13.

20.

Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology.

Hasemeier B, Christgen M, Kreipe H, Lehmann U.

BMC Biotechnol. 2008 Nov 27;8:90. doi: 10.1186/1472-6750-8-90.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk